These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28396052)

  • 1. Platelet activation and stent thrombosis.
    Georgiadou P; Voudris V
    Hellenic J Cardiol; 2017; 58(1):49-50. PubMed ID: 28396052
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term serial changes in platelet activation indices following sirolimus elution and bare metal stent implantation in patients with stable coronary artery disease.
    Marketou M; Kochiadakis GE; Giaouzaki A; Sfiridaki K; Petousis S; Maragoudakis F; Roufas K; Vougia D; Logakis J; Chlouverakis G; Vardas PE
    Hellenic J Cardiol; 2017; 58(1):43-48. PubMed ID: 28185978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrity(®) bare-metal coronary stent-induced platelet and endothelial cell activation results in a higher risk of restenosis compared to Xience(®) everolimus-eluting stents in stable angina patients.
    Szük T; Fejes Z; Debreceni IB; Kerényi A; Édes I; Kappelmayer J; Nagy B
    Platelets; 2016 Jul; 27(5):410-9. PubMed ID: 26765134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The editor's roundtable: bare-metal stents versus drug-eluting stents-indications and complications.
    Friedewald VE; Kastrati A; Roberts WC; Vetrovec GW; Windecker S
    Am J Cardiol; 2008 Jul; 102(1):32-9. PubMed ID: 18572032
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous left anterior descending and right coronary stent thrombosis after aspirin withdrawal.
    Omar HR; Mangar D; Karlnoski R; Abdelmalak HD; Camporesi EM
    Am J Emerg Med; 2012 Nov; 30(9):2093.e5-8. PubMed ID: 22386339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hyperactivity during exercise leading to iterative coronary stent thrombosis: clinical implications.
    Ormezzano O; Polack B; Vanzetto G; Sahnoun M; Machecourt J
    J Thromb Thrombolysis; 2010 Jul; 30(1):105-8. PubMed ID: 19760171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent thrombosis: an overview.
    Centemero MP; Stadler JR
    Expert Rev Cardiovasc Ther; 2012 May; 10(5):599-615. PubMed ID: 22651836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly calcific in-stent restenosis as a substrate for sirolimus-eluting stent very late stent thrombosis.
    De Maria GL; Aurigemma C; Niccoli G
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 1():S20-2. PubMed ID: 25062270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?
    Latib A; Chieffo A; Colombo A
    Monaldi Arch Chest Dis; 2007 Mar; 68(1):1-5. PubMed ID: 17564287
    [No Abstract]   [Full Text] [Related]  

  • 16. Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet...
    Nakazawa G; Ladich E; Virmani R
    Clin Pharmacol Ther; 2009 Aug; 86(2):127-30. PubMed ID: 19621005
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stent thrombosis and drug-eluting stents.
    Takayama T; Hiro T; Hirayama A
    J Cardiol; 2011 Sep; 58(2):92-8. PubMed ID: 21839615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.